NCT00658788

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of a Consecutive Treatment Regimen of Clobetasol Propionate 0.05% Spray, Followed by Calcitriol Ointment 3µg/g, in the Management of Moderate to Severe Plaque Psoriasis

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 305 (actual)
• Sponsor: Galderma R&D · Industry
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The primary objectives of this study are to evaluate the safety \& efficacy of consecutive treatments of Clobex® Spray and Silkis® Ointment in the management of plaque psoriasis.

Detailed description

Same as above.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	clobetasol propionate spray 0.05%	clobetasol propionate spray, 0.05%, applied topically twice daily
DRUG	calcitriol ointment	calcitriol ointment, 3 µg/g, applied topically, not to exceed 30 g daily

Timeline

• Start date: 2008-03-01
• Primary completion: 2009-01-01
• Completion: 2009-01-01
• First posted: 2008-04-15
• Last updated: 2022-08-23
• Results posted: 2014-08-27

Locations

12 sites across 1 country: United States